Crinetics Pharmaceuticals (CRNX): Billionaire Tom Steyer Likes This Pharma Stock
Summary
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) first appeared in the 13F portfolio of Farallon Capital in the third quarter of 2018. Back then, this position com...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.